VEGF-A Is Associated With the Degree of TILs and PD-L1 Expression in Primary Breast Cancer

Conclusion: VEGF-A expression in breast cancer may reflect PD-L1 expression in the tumor. VEGF-A may act as a negative biomarker of TILs in PD-L1-positive breast cancer. Our results suggest that VEGF-A may be predictive of immunological features and may serve as a useful biomarker for immuno-targeting therapy in patients with breast cancer.

Source: In Vivo - August 30, 2020 Category: Research Authors: FUJII, T., HIRAKATA, T., KUROZUMI, S., TOKUDA, S., NAKAZAWA, Y., OBAYASHI, S., YAJIMA, R., OYAMA, T., SHIRABE, K. Tags: Clinical Studies Source Type: research